| Liu, Ping |
NCT05064748: Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults |
|
|
| Recruiting | 4 | 2000 | RoW | Benvitimod | Peking University People's Hospital, Zhonghao Pharmaceutical | Psoriasis | 03/24 | 09/24 | | |
COPEC, NCT04922853: Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer |
|
|
| Recruiting | 3 | 554 | RoW | Capox chemotherapy | West China Hospital, The Third People's Hospital of Chengdu, Chengdu Fifth People's Hospital, Peking Union Medical College, Beijing Cancer Hospital, Sun Yat-sen University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Yunnan Cancer Hospital, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital Of Guizhou Medical University, Sichuan Provincial People's Hospital, Nanchong Central Hospital, Dazhou Central Hospital, Leshan People's Hospital, GeneCast Biotechnology Co., Ltd. | Rectal Cancer, Neoadjuvant Chemotherapy | 12/24 | 12/26 | | |
NCT06010693: A Study of Daridorexant in Chinese Patients With Insomnia Disorder |
|
|
| Completed | 3 | 206 | RoW | Daridorexant, Placebo | Jiangsu Simcere Pharmaceutical Co., Ltd. | Insomnia Disorder | 04/24 | 05/24 | | |
NCT06347653: Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) |
|
|
| Recruiting | 2 | 54 | RoW | linperlisib combined with CHOP regimen | Peking University | Nodal T-follicular Helper Cell Lymphoma | 01/27 | 01/30 | | |
NCT06378177: A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC) |
|
|
| Recruiting | 2 | 64 | RoW | LVGN6051 Monoclonal Antibody Injection, LVGN6051, toripalimab Injection, Paclitaxel injection | Lyvgen Biopharma Holdings Limited | Head and Neck Squamous Cell Carcinoma | 10/27 | 10/27 | | |
NCT04509466: Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL |
|
|
| Terminated | 1/2 | 41 | RoW | Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 1, Part 2 (treatment-naïve patients): Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 2 (treatment-naïve patients), Part 2 (relapsed or refractory patients): Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 2 (relapsed or refractory patients) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Extranodal NK/T-cell Lymphoma, Nasal Type | 01/22 | 01/22 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy |
|
|
| Not yet recruiting | 1 | 402 | RoW | Mudan granule, Mudan particle, Placebo, Placebos | Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine | Diabetic Peripheral Neuropathy Type 2 | 02/22 | 09/22 | | |
NCT04461431: Clinical Study of Posterolateral Structure of Knee Joint Under Arthroscopy |
|
|
| Recruiting | N/A | 20 | RoW | Arthroscopic anatomical reconstruction of the posterolateral structure of the knee | Peking University Third Hospital | the Posterolateral Structure of the Knee Joint, Arthroscopy, Anatomical Reconstruction | 07/20 | 01/22 | | |
NCT05214651: A Clinical Research on Repair of Massive-large Rotator Cuff Tears |
|
|
| Recruiting | N/A | 52 | RoW | novel double row, suture bridge double row | Peking University Third Hospital | Rotator Cuff Tears | 05/26 | 05/26 | | |
NCT05383521: Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis |
|
|
| Not yet recruiting | N/A | 20 | RoW | Tinidazole 56, Tinidazole M56, Tinidazole 42, Tinidazole M42 | Shangrong Fan | Trichomonas Vaginitis | 12/25 | 12/25 | | |
NCT04456881: Arthroscopic Clinical Study of Double Bundle Anatomical Reconstruction of Medial Patellofemoral Ligament |
|
|
| Recruiting | N/A | 30 | RoW | Patients with patellar dislocation undergo patellar femoral medial reconstruction | Peking University Third Hospital | Recurrent Patellar Dislocation | 02/24 | 05/24 | | |
NCT05968001: Obinutuzumab in Chinese Real-world Patients With iNHL |
|
|
| Not yet recruiting | N/A | 400 | RoW | Obinutuzumab | Affiliated Hospital of Nantong University | Lymphomas Non-Hodgkin's B-Cell | 12/24 | 07/26 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Recruiting | N/A | 10000 | RoW | No intervention | Peking University People's Hospital | Dermatitis, Atopic | 10/24 | 10/24 | | |
| Nie, Jianyun |
| Completed | 3 | 275 | RoW | GB491+ Fulvestrant, test drug + Fulvestrant, Placebo+Fulvestrant, placebo control + Fulvestrant | Genor Biopharma Co., Ltd. | Locally Advanced or Metastatic Breast Cancer | 12/22 | 03/24 | | |
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 3 | 360 | RoW | PM8002, Nab-Paclitaxel, Placebo | Biotheus Inc. | Triple Negative Breast Cancer(TNBC) | 07/27 | 07/28 | | |
JSKN003-302, NCT06079983: JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects |
|
|
| Not yet recruiting | 3 | 400 | RoW | JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection, Vinorelbine tartrate injection, Paclitaxel for injection (albumin-bound type), Docetaxel injection, Eribulin mesylate injection | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Breast Cancer | 04/25 | 03/29 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer |
|
|
| Recruiting | 3 | 6000 | Europe, Canada, Japan, US, RoW | Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane | Eli Lilly and Company | Breast Neoplasms | 10/27 | 03/32 | | |
NCT05555706: Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer |
|
|
| Recruiting | 2/3 | 450 | RoW | B013+Nab-Paclitaxel | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Triple Negative Breast Cancer (TNBC) | 06/25 | 12/26 | | |
NCT05860465: Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer |
|
|
| Recruiting | 2/3 | 254 | RoW | SPH4336 Tablets, SPH4336 Tablets Placebo | Shanghai Pharmaceuticals Holding Co., Ltd | Locally Advanced or Metastatic Breast Cancer | 03/25 | 08/25 | | |
| Ye, Lianhua |
NCT06735105: Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer |
|
|
| Recruiting | N/A | 129 | RoW | Scanning parameter | Yunnan Cancer Hospital | Gastric Cancer | 12/24 | 12/24 | | |
NCT06735118: Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver |
|
|
| Recruiting | N/A | 120 | RoW | Neoadjuvant chemotherapy, Non | Yunnan Cancer Hospital | Non-Alcoholic Fatty Liver Disease | 12/24 | 12/24 | | |
NCT06645743: Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma |
|
|
| Not yet recruiting | N/A | 1100 | RoW | | The Third Affiliated Hospital of Kunming Medical College. | Tomography, X-Ray Computed, Spread Through Air Space, Clinical Features, Stage IA Adenocarcinoma of Lung | 02/25 | 02/25 | | |
NCT06742021: Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer |
|
|
| Recruiting | N/A | 195 | RoW | Application Value of MRI Imaging in Treatment Decision-Making for Lung Cancer | Yunnan Cancer Hospital | Lung Cancer | 07/26 | 07/26 | | |
NCT06755866: DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer |
|
|
| Recruiting | N/A | 135 | RoW | The application value of MRI 4D Free Breathing DCE-MRI in the treatment of esophageal cancer | Yunnan Cancer Hospital | Esophageal Cancer | 07/26 | 07/26 | | |
| Xiang, Xu-dong |
NCT06775821: Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer |
|
|
| Recruiting | N/A | 2000 | RoW | Ultrasound or CT of the abdominal aorta | First Affiliated Hospital of Kunming Medical University, The Third Affiliated Hospital of Kunming Medical University, Kunming Medical University | Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence | 04/25 | 04/25 | | |
| Ma, Qing-yan |
NCT06775821: Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer |
|
|
| Recruiting | N/A | 2000 | RoW | Ultrasound or CT of the abdominal aorta | First Affiliated Hospital of Kunming Medical University, The Third Affiliated Hospital of Kunming Medical University, Kunming Medical University | Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence | 04/25 | 04/25 | | |
